Advanced Health Intelligence Ltd has updated shareholders regarding its activities for the quarter that ended 31 March 2023 and various partnerships of the company. The company has now completed the integration of the acquired platforms after the acquisitions of the Wellteq Digital Health Group and Vertica Health. AHI is also due to release its Biometric health assessment Software Development Kit and smartphone app. Other updates included that AHI has received $4,494,334 in funding and R&D Tax Incentive payments and recorded the highest quarterly revenue of $253,355 for the quarter ending 31 March 2023.

AHI, a client of our Bristol Investor Relations firm, is an Australian smartphone-based human scanning technology, with a diverse range of data-driven applications across multiple industries.

Read the full press release here: AHI Commentary for the Quarter Ended 31 March 2023